Oncotarget: Potent Source for Oncological Research Data

Sharing the results of scientific research is the key to advancing those studies into the future. Oncotarget is peer-review journal that focuses on oncological research as well as studies related to cancer care and treatment.

In recent months, Oncotarget has seen an increase in it readership. This has occurred primarily because the content in each issue of the journal is constructive, insightful, current, and appropriately peer-reviewed.

The editorial board of Oncotarget includes a Nobel Prize winner, Andrew Schally. Schally has seen his own papers published in Oncotarget. The fact that a Nobel Prize winner seeks to have his work published in this journal speaks volumes about the reputation and quality of content of Oncotarget.

The papers published in Oncotarget were cited over 10,000 times during the course of 2016. This represents approximately a 300 percent increase over citations in 2015. In other words, continues to glean even greater notice in the oncology research, cancer treatment, and medical communities.

Oncotarget is described as a multidisciplinary journal published on Impact Journals. It is available to researchers, medical professionals, journalists, and the public-at-large free of charge. The publication maintains that life without disease is the ultimate mission of Oncotarget.

Oncotarget has garnered attention for its focus on publishing articles and papers about oncological and associated research that currently is in progress. Publication during research allows for an important exchange of information and data that enhances the subject studies as well as others that are impacted by these particular research results.

Oncotarget was founded by Mikhail V. Blagosklonny and Andrei V. Gudkov of the Roswell Park Cancer Institute. These two cancer research specialists remain as the co-editors-in-chief of the publication. In addition to their leadership of the publication, the editorial board consists of a couple dozen other experts in the field. This includes professionals from revered institutions like Harvard Medical School, Columbia University, Stanford University School of Medicine, and John Hopkins University School of Medicine.

Follow Oncotarget on Twitter.

Global Lender Equities First Holdings Sees a Growing Trend Among Borrowers Who Use Stock as Loan Collateral to Secure Working Capital

Equities First Holdings is a global company dealing with alternative sources of capital to companies and the rich individuals. For startup companies, they are always in need of fast money to take care of their growth strategy. Therefore, capitalization is paramount even in the event of a harsh economic crisis. As a matter of fact, no one has the incredible facility management where companies engage in the issuance of fast working capital. For Equities First Holdings, they have seen an increased traction in the stock-based loans where societies are engaged in the fast working capabilities the use of stock-based and the masses increasingly adopt margin loans during the harsh economic crisis. For his reason, the company adopts a better strategy to develop fast working capital using stocks as collateral

For you to secure your fast working capital from the company, ensure you have enough stocks. For this reason, you will hand in your stocks as collateral in exchange o the money. As a matter of fact, the stock-based loans are the fastest loans in the world. They also have no qualification criteria. For you to get the money, you are not required to state the intended use of the money as a way of qualification. Therefore, enjoy the use of the loans in a manner that depicts the true nature of this capability.

Equities First Holdings is now one of the most sought companies in this line of production. As a matter of fact, most people do not understand the differences between the stock-based loans and margin loans. For the stock-based loans, you do not state the reason for securing the loan. However, you must state the reason for the money to get a qualification for the margin loans. For this reason, he stock-based loans are now better in demand than any other credit in this arena.

The History Of DAMAC Group And Hussain Sajwani

DAMAC Group is a luxury property developer that is headquartered in Dubai, United Arab Emirates. The company was originally founded by Hussain Sajwani as a catering company in 1982. Before starting the company he worked for GASCO as a Contracts Manager. Sajwani serves as the Chief Executive Officer and Chairman of DAMAC Group. He earned his university education at the University of Washington in Seattle.

DAMAC Group’s catering business stretched across the Middle East and Africa well as former Soviet Republics such as Belarus, Ukraine, Moldova, and Armenia. In the 1990’s Sajwani saw an opportunity in real estate as more and more people living and doing business in Dubai. His first projects were a number of 5 Star hotels built to cater to business class traders and entrepreneurs. In 2002 he established DAMAC Properties under the DAMAC Group umbrella and has since led the company into one of the premier property developers in the Middle East with developments in places like Doha, Abu Dhabi, Jeddah, and Beirut.As a brand that is for high-net worth individuals, Hussain Sajwani has formed partnerships with other luxury brands including Versace and Bugatti. He has also partnered with The Trump Organization on a joint development that includes an international 18 hole golf course and surrounding housing that is worth billions of dollars.

In 2011 Sajwani launched a new hospitality division of his group that provides high-end services to more than 15,000 hotel rooms and apartments. This division has led DAMAC Group to be one of the biggest hotel/apartment developers and operators in the Middle East. Another division of DAMAC Group that Sajwani has created is his DICO Investments Co LLC. Through this investment firm, Sajwani invests in global Equities First with a specialization in private equities, mergers, and acquisitions.Hussain Sajwani has made a number of charitable donations over his career. Among these is a one milion AED donation to UAE Red Crescent. The donation designed to help the thousands of refugees in Lebanon and Jordan and in particular Sajwani’s donation was targeted at the hardest hit areas. In a statement, he commented that he felt it was his humanitarian duty to help.

 

Jeanmarie Guenot Makes Accomplishments in Cancer Treatment

 

JeanMarie Guenot is currently the chief executive officer of an institution known as Amphivena Therapeutics. Under her leadership, the company has accomplished a lot. Not long ago, Jeanmarie announced to the investors that the Food and Drug Administration agency had accepted an application to start an investigative trial in one of the drugs from Amphivena Therapeutics that was developed to fight cancer. The special drug is known as AMV564, and reports say that it works with other proprietary antibodies from Amphivena Therapeutics to achieve its objectives.

 

JeanMarie Guenot says on Facebook, that she is fully prepared to significantly expand the institution’s product availability as part of the application acceptance. Jean says that the drug will be introduced to new patients soon. By increasing the scope of the trial, Amphivena Therapeutics will quickly gather information about the effectiveness of the new drug and adapt to all its metrics easily. Today, the drug is being marketed to help the patients who are suffering from acute myeloid leukemia.

 

During the first stage of the drug trial, Takeda’s website details how Jeanmarie and her company will study the safety of raising the dosage of the drug doses to the cancer patients. When the experts have completed evaluating the data rigorously, Amphivena Therapeutics will now be able to review the effectiveness of the drug in curing the different rumors and preventing more from developing. The leadership team in the company will work closely with Jean-Marie to design extraordinary measures that will take into account the safest dose for the patients through this process. The measures will also ensure that the consumer has no side effects when they start using the drug. The information acquired will also help the health care company to transition into the second part of its program. The second phase will put the drug in serious and rigorous testing.

 

Amphivena Therapeutics has won the hearts of many people in the recent times for tirelessly working to introduce new and better innovative ways to cure cancer. The news proves that Jean Marie is working hard, and she is allowing her Ph.D. Get wasted. Marie has also ensured that the financial side of the company is not affected by looking for the funding needed to accomplish the new program.

Erick Lefkofsky And His Selfless Contributions To His Community

Erick Lefkofsky is a remarkable entrepreneur who has displayed his brilliance with a stellar track record. He is a man who has generously contributed towards noble courses and mostly in his Chicago hometown. Most of his contributions have been made in the fields of arts and culture though he has contributed notably in areas like education, technology, Health, and Human Rights. Erick and his wife Liz formed the Lefkofsky Family Foundation that aimed at supporting educational organizations, philanthropic, and scientific causes across the world. Refer to https://en.wikipedia.org/wiki/Eric_Lefkofsky

 

Erick is known for his primary role in the founding of Groupon; a company he served as the CEO till 2015 when he decided to move onto his next project. He is also known for his major role in the campaign against cancer. In this field, he has adopted a different strategy to combat the ailment that is going to help physicians make significant breakthroughs. Tempus; the name of this company, aims to modernize the fight against cancer by creating a library of clinical and molecular data and an OS that makes the data accessible and most importantly useful.

Read http://www.chicagobusiness.com/article/20161001/ISSUE01/310019995/can-eric-lefkofsky-save-your-life

 

Tempus gives physicians the ability to offer each patient personalized care through the interactive analytical and the machine learning platform. They also offer genomic sequencing services and also analyze therapeutic and molecular data to enable physicians to make informed decisions based on solid evidence. At Tempus, the treatment of each patient is well documented because it is vital for the treatment of other patients after him as well.

 

Erick can be described as a serial entrepreneur who began his career in his college days. He has since created, bought, and sold one numerous company. This culminated with the formation of Groupon; which turned out to be a tech darling. He studied at the University of Michigan where he attained Doctor of Jurisprudence and a bachelor’s degree in Arts/Science. He has also authored the book “Accelerated Disruption: Understanding the True Speed of Innovation” in this book Erick Describes how disruptive businesses are founded, developed and sustained. It also provides a framework for making your idea a reality that is both intelligent and conceptual.

Securus Technologies Helped Inmate take Medicine

Securus Technologies, you have really helped my daughter. She is diabetic and is on medication. Since she has been in jail, her numbers have been steady for the most part. Then, all of a sudden, she began to have problems. She was having slight seizures. She seemed not responsive at times. When we asked her if she was alright, she said she was fine. We asked her if she was taking her medicine. She said she was taking her meds. We came to the conclusion that her diabetes medicine might need to be adjusted. We spoke to the authorities and they assured us that they would look into the matter. Two weeks later, we were called with the findings. According to Securus Technologies, my daughter had not been taking her medication properly.She would hold it in her mouth and spit it out at her earliest convenience. She had actually gotten depressed by being in jail and started to harm herself by not not taking her meds. This is what was discovered as Securus Technologies listened to the recorded tapes of my daughter talking over the phone. She was confessing this to her friends because she felt they wouldn’t let anyone else know,and they didn’t. But Securus Technologies was able to catch it. Aad they addressed it by giving my daughter anti-depressant medication. Now she is so much better. She is taking all of her medicine everyday and on time. She is better overall. We never would have known what the real problem was if it wasn’t for Securus Technologies. That program is doing more good than what people are giving them credit for. My daughter can hardly believe now that she let herself slip that far away from her goals of succeeding in life. Thank you Securus Technologies for your program.

 

Investor Arthur Becker Acquires New Properties in SoHo

Recently, tech investor Arthur Becker took action in order to build on his already impressive investment portfolio. He recently looked to acquire some new real estate in one of the trendiest neighborhoods in New York City. Becker bought three townhomes in the SoHo District. With the acquisition of these townhomes, Becker will be in position to have real estate that will likely rise in value and allow him to profit from high returns in the future. Over the years, Becker has been quite active in and supportive of real estate investing in New York City. He has looked to acquire a number of properties in order to compliment his technology company holdings.

According to a number of recent reports, Arthur Becker has invested up to $20 million in this recent real estate project. This amount of money was used in order to acquire the properties which will hopefully give Becker a high return once he is looking to sell them. With the investment of these three townhomes, Becker will be able to control property in one of the most desirable neighborhoods in New York City. The properties will give him a prestigious residential location as well as providing him with properties that will appeal to many who wish to be residents of the SoHo District.

In order to get these townhomes in the SoHo District, Becker invested an estimated $20 million. With this amount of money, he will be in position to own some of the most valuable real estate in New York City. He is currently the owner of the three townhomes with addresses of 10, 30 and 50 Sullivan Street. With these new properties, Becker looks to live in one and lease out the other two. By living in one of the properties, Arthur will have a prime residential location in the city. This will give him a very luxurious place to live in one of the top neighborhoods in the city. As well as living in a nice townhome, Arthur Becker looks to receive rental income from his other two properties as well. Therefore, the three properties he bought will provide him with a key component of his overall investment portfolio.

Making Money Seems to Come Naturally to Todd Lubar

Some persons just seem to have what it takes to easily make money. There are some young professionals that can attain startup funds without batting an eye; and others that make money like it was growing on trees. The latter is true of Todd Lubar. He is and truly remains an exceptional business personality in the field of mortgage banking and brokering and the financial industry.

 

Todd made his entry into the real estate industry in 1995. He knew instinctually that he was interested in becoming involved in the business. Todd had a strong yearning to assist consumers in reaching their financial goals. It was at this juncture that Lubar told himself he would involve himself in the real estate profession.

 

He began his journey as a loan originator at Crestar Mortgage Corporation. Todd, learned, within a relative short period of time, how to perform the necessary procedures in order to get his clients accepted for conventional loan arrangements. He further established quick and life-long rapports with persons in the real estate marketing industry, financial planning professions, and insurance industry. The preceding type of professional representatives are part of Lubar’s extensive network of business contacts.

 

Todd, moved his career a step further, by acquiring an equity position within the Legacy Financial Group. In doing so, he was able to expand upon his lending options; providing his client base with a greater sampling of products and services. He could broker loans to investors on the outside; and still work in the capacity of a mortgage banker.

 

Lubar, in 2002, decided to take his financial focus up one level. He opened up a limited liability corporation by the name of Legendary Properties, LLC. The preceding company was a residential development organization. Within this company, he performed the services of buying, rehabbing and selling houses. He was able to profit from over two-hundred transactions, through the company. His transactions included that of single-family homes and multiple units. He further developed his network of professionals while at Legendary Properties. The network consisted of persons and companies engaged in the construction trade. He needed to establish such contacts in order to assure the properties, which he purchased, were turned over in a timely manner. He established, too, a rapport with primary banking establishments. Todd, in so doing, was able to grow his line of credit as high as twenty-million dollars.

 

During 2003, Lubar maintained his involvement within the industry of mortgage banking. He opened up a subsidiary company referred to as Charter Funding. The affiliation with Charter made it possible for Todd to increase his business even further.

 

Todd, at this point, had made observations of the market for over a twelve-year period. He noticed, in so doing, a market niche that was going unnoticed. As a result of it, he established a limited liability corporation: Legendary Financial, LLC. The limited liability corporation was an affiliate of Legendary Properties, LLC. The company was set up as a commercial lending source for individuals and corporations. He made use of Legendary Funding’s liquidity as well as his own funds to lend money to borrowers who otherwise would have been passed by, by traditional banks and other traditional lending sources. Todd, in so doing, was involved in over seven-thousand transactions. He, by this point, was very good at analyzing the overall risk that the borrower presented to the lender. He easily could formulate lending decisions, based on his ability to assess this risk.

 

The mortgage industry experienced some major changes during the time period of 2007 to 2008. Lubar, during this period of time, became involved in several other business models. He worked in the administrative end of a dismantling service; obtaining some very impressive contracts from some of the largest general contracting firms in the United States. He also became involved in the administrative-operations end of a recycling business—which proved highly successful.

 

Todd is a resident of Bethesda, Maryland. He enjoys spending time with his two children. He mentions that he likes the lifestyle, too, of southern, California.

 

He takes time off from business affairs traveling and participating in various educational and recreational activities with his children. He mentions that he makes it his rule to continue to better himself. He wishes to become a better person tomorrow than what he is today. He states, too, that he wants to add value to the lives of all the people which he comes in contact, on a daily basis. Probably: it is the preceding selfless attitude that allows Lubar to continue to be a huge financial success. Todd is currently President of TDL Global Ventures, LLC.

Dr. Jennifer Walden: Plastic Surgeon Extraordinaire

Aesthetic plastic surgeon Dr. Jennifer Walden is a Texas Girl through and through. Although she spent over 10 years working in Manhattan, she recently returned to her Austin home, with her young sons Houston and Rex in tow. Not one to let the grass grow under her feet, Dr. Jennifer Walden opened The Walden Cosmetic Surgery Center in Austin.

 

Dr. Walden is considered among the best in the business. She is highly respected by her peers and receives high praise from her patients. She performs a full line of procedures. Most of it is aesthetic surgeries like breast augmentation, liposuction, Botox, facial and brow lifts and non-invasive laser treatments.

 

After graduating from the University of Texas with a degree in biology, she was waitlisted as she tried to gain entrance into The University of Texas Medical Branch. She finally got in and graduated salutatorian. She received a fellowship to work at the prestigious Manhattan Eye, Ear and Throat Clinic. She also worked at New York University Langone Medical Center as a plastic surgery instructor.

 

Dr. Walden enjoyed her time in New York, but after the birth of her twin boys Houston and Rex, she decided to pull up stakes and head South. She has a big family back home and thought it was best to have her young sons grow up with family. Who can argue that?

 

Dr. Walden’s wild success has followed her. She is one of the most highly sought-after aesthetic plastic surgeons in Texas. Her interests focus solely on women’s health issues. Dr. Walden wants to empower as many women as she can in all areas of life.

How Maggie Gill Persevered Before and During Leadership at Memorial Health

Margaret “Maggie” Gill is perhaps one of the most hands-on Chief Executive Officers that walked on this planet, for the reason that she has done and is still doing so much for Memorial Health, a company that manages the Memorial University Medical Center located in Georgia.

Education

Maggie Gill was a very intellectual student during her scholastic years. When she went out of the Florida State University, she got her Bachelor’s degree with honors. For a Master’s degree in Business Administration, Gill then entered the Saint Leo University within the same state. In addition to that, she took a brief course in strategic thinking and management at Wharton School to increase her skills.

Employment

Before Maggie Gill became an important member of Memorial Health, she was the Chief Financial Officer for Tenet South Florida Health System for five years. This job post enabled her to work at the North Shore Medical Center, the Coral Gables Hospital, and the Palmetto General Hospital which are all within Florida as well. Her contributions to this company were not left undetected by her superiors at the time, as she received a total of three Tenet Outstanding CFO Awards while she was there.

When Maggie Gill got hired by Memorial University Medical Center in 2004, she held the vice presidency position for the finance or managed care department, and then encouraged to the Chief Finance Officer post by 2005. During the period in which Memorial Health could not decide on who would be the next CEO and President after the last one stepped down, it was Maggie who temporarily filled in the spot. However, she did not have to vacate her place at the helm of the company because the Board of Directors and other executives voted for her to obtain the roles above permanently in 2011.

Memorial Health

Her work in Memorial Health is not for the faint of heart, as Maggie Gill directly manages all the vice presidents and medical heads of the company. Also, she handles various matters within MUMC, including government and physician relations, auditing, and financial management and assistance, to name a few.

Under Maggie Gill’s leadership, the company attained many accolades from the recent 16th Annual Health Care Heroes Awards created by the Georgia Medical Society. The achievements focused on The Primary Care Accelerated Track Program and Teen Drivers Program that they currently have, as well as select sponsors, organizations, and physicians who support the medical center tirelessly.